Cannage Capital
Status
ACTIVE
Global HQ
Las Vegas, United States
Countries of investment
- United States
Investment stages
- Pre-Seed
- Seed
- Series A
Industries
- AI
- Deep Tech
- Health Tech
- Fintech
- Cybersecurity
- Robotics
About
Cannage Capital is a Las Vegas-based venture capital firm focused on artificial intelligence. Their focus spans semiconductors, software infrastructure, healthtech, fintech and robotics across the United States. The firm supports founders from pre-seed through Series A stages.
Cannage Capital is a Las Vegas-based venture capital firm focused on artificial intelligence. Their focus spans semiconductors, software infrastructure, healthtech, fintech and robotics across the United States. The firm supports founders from pre-seed through Series A stages.
Investment Thesis
Cannage Capital is a pre-seed to Series A stage firm investing across the AI stack, from semiconductors and software infrastructure to applications in industries such as health, finance and security. The firm differentiates itself through an interdisciplinary approach and a team that previously backed Cruise, Covariant, Hinge Health and Sardine.
Manager's Experience
Founded in 2024 in Las Vegas by Shelley Zhuang, who holds a PhD in Computer Science from UC Berkeley, with partner Jake Smith. Zhuang previously founded 11.2 Capital, whose $49M debut fund made a seed investment in Hinge Health that became a stake worth roughly $200M at IPO. The team has previously backed Cruise, Covariant, Sardine, Forter and Ginkgo Bioworks.
Team
Shelley Zhuang - Founder & Managing Partner
Jake Smith - Partner
Tien Tran - CFO
Portfolio
Airrived
Noetik
Deep Genomics
Ginkgo Bioworks
Cruise
Hinge Health
Covariant
Sardine
Forter
HUMAN